CVS Caremark (CVS) Continues Higher as FTC Drops Investigation
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) is continuing higher Thursday, following a release that the FTC has dropped an investigation into the company's business practices.
Shares are now up 0.7 percent on the session, continuing to hit intraday highs.
Shares are now up 0.7 percent on the session, continuing to hit intraday highs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
- CVS Pharmacy® and MinuteClinic® now offering updated flu vaccines nationwide
- CVS Pharmacy® launches Home Team Heroes contest to celebrate youth soccer players
Create E-mail Alert Related Categories
Insiders' Blog, Litigation, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
